Índice triglicerídeo-glicose como preditor para doenças cardiovasculares em pacientes com diabetes tipo 2: uma revisão sistemática
Data
2024-08-23
Autores
Mota, Alexia Correia 
Orientadores
Pereira, Edimar Cristiano
Tipo
Trabalho de conclusão de curso
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Em um contexto mundial, onde a população está vivendo cada vez mais, a longevidade saudável é vista como um dos aspectos mais importantes dentro das populações. Para que este aspecto seja atendido, doenças crônicas vêm sendo cada vez mais estudadas para que haja um tratamento preventivo e eficaz, evitando assim a morte precoce dos indivíduos. Neste sentido, muitos estudos concentram suas pesquisas na prevenção de doenças que podem ser causadas devido à comorbidades já existentes, como a dislipidemia, em pacientes diabéticos tipo 2. Estudos recentes trazem a relação entre eventos cardiovasculares adversos com dislipidemia e diabetes tipo 2. O intuito destes é descobrir marcadores promissores que auxiliem os pacientes a escaparem dos desfechos desfavoráveis existentes destas doenças. Desta forma, a revisão sistemática desta monografia tem o objetivo de reunir artigos científicos que trazem o índice triglicerídeo-glicose como potencial indicador de risco de doenças cardiovasculares, o qual encontra-se alterado em pacientes diabéticos com dislipidemia. Na análise do índice, proposta por um exame de sangue nos estudos contidos nesta monografia, simplifica a identificação dos possíveis riscos de doenças cardiovasculares futuras, proporcionando a possibilidade de tratamentos medicamentosos e preventivos direcionados na mudança de estilo de vida do indivíduo. A adição deste marcador nos exames laboratoriais das populações do mundo impactará positivamente na longevidade dos pacientes que possuem diabetes tipo 2, uma das maiores doenças crônicas do século XXI.
In a global context where the population is living longer, healthy longevity is seen as one of the most important aspects within populations. In order to address this aspect, chronic diseases have been increasingly studied to enable preventive and effective treatments, thus avoiding premature death. In this regard, much research has focused on preventing diseases that may arise due to existing comorbidities such as dyslipidemia in type 2 diabetic patients. Recent studies have highlighted the relationship between adverse cardiovascular events and dyslipidemia in type 2 diabetes. The aim of these studies is to discover promising markers that assist patients in avoiding the unfavorable outcomes associated with these diseases. Therefore, the systematic review in this thesis aims to compile scientific articles that explore the triglyceride-glucose index as a potential indicator of cardiovascular disease risk, which is altered in diabetic patients with dyslipidemia. By analyzing this index through blood tests as proposed in the studies within this thesis, it simplifies the identification of potential risks of future cardiovascular diseases, thereby enabling targeted preventive treatments focusing on lifestyle changes for individuals. Incorporating this marker into routine laboratory tests worldwide is expected to positively impact the longevity of type 2 diabetic patients, one of the major chronic diseases of the 21st century.
In a global context where the population is living longer, healthy longevity is seen as one of the most important aspects within populations. In order to address this aspect, chronic diseases have been increasingly studied to enable preventive and effective treatments, thus avoiding premature death. In this regard, much research has focused on preventing diseases that may arise due to existing comorbidities such as dyslipidemia in type 2 diabetic patients. Recent studies have highlighted the relationship between adverse cardiovascular events and dyslipidemia in type 2 diabetes. The aim of these studies is to discover promising markers that assist patients in avoiding the unfavorable outcomes associated with these diseases. Therefore, the systematic review in this thesis aims to compile scientific articles that explore the triglyceride-glucose index as a potential indicator of cardiovascular disease risk, which is altered in diabetic patients with dyslipidemia. By analyzing this index through blood tests as proposed in the studies within this thesis, it simplifies the identification of potential risks of future cardiovascular diseases, thereby enabling targeted preventive treatments focusing on lifestyle changes for individuals. Incorporating this marker into routine laboratory tests worldwide is expected to positively impact the longevity of type 2 diabetic patients, one of the major chronic diseases of the 21st century.